MTOR and colonic neoplasm: To identify additional prognostic biomarkers associated with the drug sensitivity in colon cancer cells, different gene expression profiles between sensitive and resistant colon cancer cells responding to the chemotherapy, BRAF inhibitors and PI3K-mTOR inhibitors treatment were identified.